Abstract:Novel monometallic and heterobimetallic complexes of Zn (II) were synthesized. The newly designed complexes were characterized by infrared (FT‐IR), nuclear magnetic resonance (NMR), electron spray ionization mass spectrometry, powder X‐ray diffraction, molar conductivity, and UV–vis. Density functional theory calculations were performed to calculate the stability and chemical reactivity of the newly designed Zn (II) complexes. In vitro antimicrobial, anti‐inflammatory, and anticancer activities of the newly synthesized complexes were evaluated. In the present work, new heterobimetallic complexes with the general formula [Zn(C16H32N8)M2(R)4Cl2], where M = Sn (IV) and Si (IV) and R = ‐CH3 and ‐C6H5, were synthesized by reacting the methanolic solution of the monometallic complex [Zn(C16H36N8)Cl2] with group 14 organometallic dichloride [(CH3)2SnCl2/(C6H5)2SnCl2/(CH3)2SiCl2/(C6H5)2SiCl2]. The structures of the synthesized complexes were determined using several spectrometric techniques, including FT‐IR, 1H NMR, 13C NMR, 119Sn NMR, 29Si NMR, ESI‐MS, PXRD, and molar conductivity measurements. Density functional theory (DFT) calculations were carried out to investigate the quantum chemical characteristics of the newly synthesized Zn (II) complexes. The antimicrobial potential of the monometallic and heterobimetallic complexes was evaluated against two Gram‐positive bacteria (Bacillus subtilis and Bacillus cereus), two Gram‐negative bacteria (Xanthomonas campestris and Pseudomonas aeruginosa), and two fungal strains (Aspergillus flavus and Fusarium oxysporum) by the agar well diffusion method, with heterobimetallic complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] as the most potent complex against microbes. The complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] exhibited significant potential in inhibiting inflammation, demonstrating an IC50 value of 9.75 μg/mL, which closely rivals that of the standard drug sodium diclofenac (IC50 = 4.59 μg/mL). Furthermore, all the synthesized compounds were assessed for their anticancer potential against three cancer cell lines (HCT‐116, MCF‐7, and HeLa) by the MTT assay. The results indicated that the complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] exhibited the most pronounced cytotoxic effects, with values of 4.25 ± 0.15 μM, 4.90 ± 0.18 μM, and 5.20 ± 0.24 μM observed for HCT‐116, MCF‐7, and HeLa cancer cell lines, respectively.

A novel zinc complex with antibacterial and antioxidant activity

Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies

Syntheses, Crystal Structures and Antitumor Activity of Ni((II)/Zn(II) Complexes Containing Cephalexin Hydrolysate

Antioxidant and Antimicrobial Properties of Nickel(ii), Cobalt(iii), and Zinc(ii) Complexes of a Schiff Base Ligand

Synthesis, Crystal Structures and Antibacterial Activity of Nickel(II), Cadmium(II) and Zinc(II) Complexes with Hydrazone Ligands

Synthesis, characterization and antioxidant, antibacterial activity Zn2+, Cu2+, Ni2+ and Co2+, complexes of ligand [2-(thiophen-2-yl)-1-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole]

Crystal structures and antimicrobial activity of zinc(II) and nickel(II) complexes of 5-bromo-(((2-(phenylamino)ethyl)imino)methyl)phenol

Synthesis, characterization and antibacterial activity of [Zn(formato)2(4,4′-bipy)] complex

Ceftriaxone-based Schiff base transition metal(II) complexes. Synthesis, characterization, bacterial toxicity, and DFT calculations. Enhanced antibacterial activity of a novel Zn(II) complex against S. aureus and E. coli

Manganese(II) and Zinc(II) metal complexes of novel bidentate formamide-based Schiff base ligand: synthesis, structural characterization, antioxidant, antibacterial, and in-silico molecular docking study

Preparation and activity evaluation of zinc ion delivery system based on fucoidan-zinc complex

Synthesis, crystal structure, phosphate hydrolysis activity and antibacterial activity of macrocyclic dinuclear Zn(II) complex with benzyl pendant-arms

Synthesis, Structural Elucidation, Density Functional Theory Calculations, In Vitro Antimicrobial, Anti‐Inflammatory and Anticancer Activities of Novel Zn (II)‐Group Fourteen Heterobimetallic Complexes Derived From Schiff Base Ligand

Synthesis, crystal structure and in vitro antibacterial activity of two novel silver(I) complexes

Syntheses, Characterization and Crystal Structures of Schiff Base Zinc(II) Complexes with Antibacterial Activity.

Synthesis, kinetics, mechanisms, and bioactivity evaluations of a novel Zn(II) complex

Synthesis, Crystal Structure and Antimicrobial Activities of A Novel Schiff Base Zinc(Ii) Complex

A green chemistry approach for preparation of metronidazole-zinc (ІІ) complexes: In vitro characterization, antimicrobial activity and promising cytotoxicity

From 0D-complex to 3D-MOF: changing the antimicrobial activity of zinc(II) via reaction with aminocinnamic acids

A Comprehensive Mechanistic Antibacterial and Antibiofilm Study of Potential Bioactive ((BpA)2bp)Cu/Zn Complexes via Bactericidal Mechanisms against Escherichia coli

Anticancer, antioxidant, and antimicrobial studies and molecular docking of a new hexanuclear Zn(ii) complex, together with its X-ray crystal analysis